Phoenix Cardiac Devices announces start of clinical trial in India and Europe to test BACE™ device for treatment of mitral regurgitation without open heart surgery (via PR Newswire)
Study to assess safety and efficacy with goal of obtaining CE Mark approval CHICAGO, Jan. 14, 2013 /PRNewswire/ — Phoenix Cardiac Devices, Inc., a medical device company with a novel method of repairing leaky heart valves without open-heart surgery, has enrolled its first patient in a clinical trial…
published: January 16, 2013 in: Cardio, Clinical Studies/Trials